Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05545306 · ClinicalTrials.gov registry record · NA

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

A NA study of Obesity and Healthy Volunteers, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05545306: Recruiting NA study of Obesity and Healthy Volunteers, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT05545306 is a NA study of Obesity and Healthy Volunteers that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05545306, a NA study of Obesity and Healthy Volunteers, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Background: Diet-induced thermogenesis (DIT) is the amount of energy one s body uses to eat food, absorb the nutrients from the food, and process those nutrients. Researchers would like to understand more about how changing the balances of protein, fat, carbohydrates, and total calories in the diet can affect DIT. Objective: To learn how different diets can change a person s DIT. Eligibility: Healthy people aged 18 to 60 years who have not intentionally lost weight in the past 6 months. Design: Participants will stay in a clinic for about 35 days. They will eat only the food provided. They will receive 8 different diets during the study, including 7 test diets. Participants will undergo multiple tests. They will be screened with blood and urine tests and a test of their heart function. During the first few days: Their waist, thigh, and neck circumference will be measured. They will have a DXA scan: They will lie on a padded table for about 20 minutes while an instrument measures the amount of fat in their body. They will be tested for diabetes. They will answer questionnaires about topics including eating behavior, hunger, and stress. Throughout the study: Their weight will be measured daily. Blood tests will be repeated. They will stay in a metabolic chamber a total of 9 times. They will remain in a closed room for 24 hours while researchers monitor the room temperature and levels of oxygen and carbon dioxide. Participants will collect all their urine for each 24-hour period. ...

Primary Outcome

DIT is calculated from 24h EE during feeding-24h EE during fasting under different caloric loads

Interventions

  • DIETARY_SUPPLEMENT +200% of dietary requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat
  • DIETARY_SUPPLEMENT fasting
  • DIETARY_SUPPLEMENT -50% of energy balance requirements. 50% of calories from carbohydrates, 20% from protein, and 30% from fat
  • DIETARY_SUPPLEMENT +150% of energy balance requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat
  • DIETARY_SUPPLEMENT +200% of dietary requirements, 51% of the calories from carbohydrates, 46%, from fat and 3% from protein

Study Locations (1)

Arizona

  • NIDDK, Phoenix - Phoenix

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-06-06
Est. Completion 2027-02-02
Phase NA

What NCT05545306 shows while recruiting

NCT05545306 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which +200% of dietary requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat is the first listed.

NCT05545306 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT05545306 about?

NCT05545306 is a clinical study titled "The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure". Background: Diet-induced thermogenesis (DIT) is the amount of energy one s body uses to eat food, absorb the nutrients from the food, and process those nutrients. Researchers would like to understand more about how changing the balances of protein, fat, carbohydrates, and total calories in the diet...

What is the current status of trial NCT05545306?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-06-06. Estimated completion is 2027-02-02.

What conditions does trial NCT05545306 study?

This clinical trial studies the following conditions: Obesity, Healthy Volunteers, Normal Physiology.

What interventions are being tested in trial NCT05545306?

The interventions under investigation include: +200% of dietary requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat (DIETARY_SUPPLEMENT), fasting (DIETARY_SUPPLEMENT), -50% of energy balance requirements. 50% of calories from carbohydrates, 20% from protein, and 30% from fat (DIETARY_SUPPLEMENT), +150% of energy balance requirements, 50% of calories from carbohydrates, 20% from protein, and 30% from fat (DIETARY_SUPPLEMENT), +200% of dietary requirements, 51% of the calories from carbohydrates, 46%, from fat and 3% from protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05545306?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05545306 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05545306's enrollment target sits among peer trials

120 434th of 1053 higher than 607 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05545306, the US trial registry maintained by the National Library of Medicine. NCT05545306 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.